Cara Therapeutics Overview
Cara Therapeutics Discounted Cash Flow
DCF Analysis for CARA.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.13
Current Fair Value
$0.13
↓ 97.6% Downside
Overvalued by 97.6% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison